Learn the latest news about the CAT Facility and tips for learning flow cytometry. Feel free to share your opinion in the comments section of each post. The comment section will be moderated for tone and content.
We had Omar Abouzid from EasyPanel to discuss the new developments that comes with version 2. I've been pretty happy with the tool so far, but I'm now very excited to see how the new antibody inventory system will work out. The panel design tool itself has a few...
David Leclerc | Oct 30, 2023 | 0 Comments
The former Director of the CAT Facility, Ryan Duggan, had a good thing going with a Google Group in cytometry, before Google decided to shut down that tool. He was hosting Google hangouts, called Cytometry on Air, to discuss all things flow cytometry, which...
David Leclerc | Oct 14, 2023 | 0 Comments
We're back from Madison where Everett and myself attended the GLIIFCA 2023 meeting. Mind you, I'm on the Board of Directors of that meeting so I'm a bit biased here. But it's a great meeting! It's only two days so the scientific content is distilled to its purest,...
David Leclerc | Sep 28, 2023 | 0 Comments
Edit 01/16/24: I was just pointed to the Flow Cytometry subreddit, created by Daniel Vocelle at CSU. I have been missing out on it for all these years. I'm so old. It's more active than the Purdue list, and probably more useful at this point. I've been looking at...
David Leclerc | Aug 9, 2023 | 0 Comments
CYTO 2023 has come and gone, here are a few thoughts on this year's edition: Flow Cytometry in the back seat: There were few plenary sessions where flow was front and center. Maybe the technology is so mature now that it's not cool anymore? There was a lot of...
David Leclerc | Jun 22, 2023 | 0 Comments
The main thing that struck me during the 2022 ChUG Cytometry Workshop held in November is the incredible amount of tools that were developed over the last few years to make of flow cytometry lives easier. Amongst them is the EasyPanel online algorithm that rapidly...
David Leclerc | Dec 10, 2022 | 2 Comments
Get notified of new posts, opt out any time.
This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
